Your browser doesn't support javascript.
loading
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis.
Ichikawa, Masataka; Nakamoto, Nobuhiro; Kredo-Russo, Sharon; Weinstock, Eyal; Weiner, Iddo Nadav; Khabra, Efrat; Ben-Ishai, Noa; Inbar, Dana; Kowalsman, Noga; Mordoch, Ron; Nicenboim, Julian; Golembo, Myriam; Zak, Naomi; Jablonska, Jagoda; Sberro-Livnat, Hila; Navok, Sharon; Buchshtab, Nufar; Suzuki, Takahiro; Miyamoto, Kentaro; Teratani, Toshiaki; Fujimori, Sota; Aoto, Yoshimasa; Konda, Mikiko; Hayashi, Naoki; Chu, Po-Sung; Taniki, Nobuhito; Morikawa, Rei; Kasuga, Ryosuke; Tabuchi, Takaya; Sugimoto, Shinya; Mikami, Yohei; Shiota, Atsushi; Bassan, Merav; Kanai, Takanori.
  • Ichikawa M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Nakamoto N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan. nobuhiro@z2.keio.jp.
  • Kredo-Russo S; BiomX Ltd., Ness Ziona, Israel.
  • Weinstock E; BiomX Ltd., Ness Ziona, Israel.
  • Weiner IN; BiomX Ltd., Ness Ziona, Israel.
  • Khabra E; BiomX Ltd., Ness Ziona, Israel.
  • Ben-Ishai N; BiomX Ltd., Ness Ziona, Israel.
  • Inbar D; BiomX Ltd., Ness Ziona, Israel.
  • Kowalsman N; BiomX Ltd., Ness Ziona, Israel.
  • Mordoch R; BiomX Ltd., Ness Ziona, Israel.
  • Nicenboim J; BiomX Ltd., Ness Ziona, Israel.
  • Golembo M; BiomX Ltd., Ness Ziona, Israel.
  • Zak N; BiomX Ltd., Ness Ziona, Israel.
  • Jablonska J; BiomX Ltd., Ness Ziona, Israel.
  • Sberro-Livnat H; BiomX Ltd., Ness Ziona, Israel.
  • Navok S; BiomX Ltd., Ness Ziona, Israel.
  • Buchshtab N; BiomX Ltd., Ness Ziona, Israel.
  • Suzuki T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Miyamoto K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Teratani T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Fujimori S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Aoto Y; JSR-Keio University Medical and Chemical Innovation Center (JKiC), JSR Corp., Tokyo, Japan.
  • Konda M; JSR-Keio University Medical and Chemical Innovation Center (JKiC), JSR Corp., Tokyo, Japan.
  • Hayashi N; JSR-Keio University Medical and Chemical Innovation Center (JKiC), JSR Corp., Tokyo, Japan.
  • Chu PS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Taniki N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Morikawa R; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Kasuga R; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Tabuchi T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Sugimoto S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Mikami Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
  • Shiota A; Department of Microbiology and Immunology, Keio University, Tokyo, Japan.
  • Bassan M; Microbiopharm Japan, Co. Ltd., Tokyo, Japan.
  • Kanai T; BiomX Ltd., Ness Ziona, Israel.
Nat Commun ; 14(1): 3261, 2023 06 05.
Article en En | MEDLINE | ID: mdl-37277351

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangitis Esclerosante / Terapia de Fagos Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colangitis Esclerosante / Terapia de Fagos Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article